Partnering with an experimented CRO based in Europe and North-America
In the dynamic landscape of pharmaceutical innovation, partnering with a reliable CRO has become increasingly essential for biotech and pharmaceutical companies seeking to bring new therapies to market efficiently and effectively. At Oncodesign Services, we are proud to offer comprehensive drug development and preclinical services, seamlessly bridging the gap between discovery and clinical stage.
A long-term “partner research organization”
With laboratories located in Europe and North America, Oncodesign Services provides a global footprint ensuring proximity to key markets and regulatory authorities, facilitating streamlined communication and regulatory compliance throughout the drug development process.
As a pioneer in translational pharmacology to evaluate the efficacy of treatments, the company is able to bring value to your project through a diverse range of skills and personalized support, from hit-finding to lead optimization. We offer integrated solutions in biophysics, medicinal chemistry, bioanalysis, DMPK, Molecular Imaging up to in vitro/in vivo pharmacology.
Our multidisciplinary approach enables us to tackle complex scientific challenges and accelerate the progression of novel therapies in oncology, inflammation, infectious diseases and more. Oncodesign Services has succeeded in developing several drug candidates that have reached the clinical development phase together with its partner clients.
Over 25 years of experience in Drug Discovery
Furthermore, our diverse team of experts brings together a wealth of experience and expertise from across the pharmaceutical industry. Whether it’s designing custom assays, optimizing lead compounds, or conducting complex animal studies, our scientists are committed to delivering innovative solutions tailored to each client’s unique objectives.
With stringent protocols in place, including Good Laboratory Practices (GLP) and our AAALAC International accreditation, we ensure the integrity and reliability of our data, instilling confidence in our clients and regulatory authorities alike.
In an era where outsourcing recommendations are strengthening, Oncodesign Services stands ready to be your trusted partner in drug development! Our team will be happy to present more information about our services and how we can support your drug development initiatives. Please visit our website or contact us directly.
Progress your molecule to IND
We have built a team of drug discovery experts to provide innovative solutions through the entire drug discovery journey from hit-finding to IND-filing with state-of-the-art capabilities
Biophysics
h3>Biophysics
Biophysics plays a crucial role in the early stages of drug discovery by identifying and characterizing small molecules and biologics for specific targets. ZoBio, an associated company of Oncodesign Services, leverages their expertise in this field to provide custom biophysical assays.
Medicinal Chemistry
Bioanalysis
Bioanalysis
Oncodesign Services offers formulation, immunogenicity and bioanalytical sample analysis services including platforms for small molecules (NCEs), peptides, large molecules (NBEs), monoclonal antibodies (mAb), Antibody-Drug Conjugates (ADC), Anti-Drug Antibodies (ADA), Neutralizing Antibodies (Nab), oligonucleotides (OGN) and biomarkers (simplex/multiplex).
In vitro biology
In vitro biology
Oncodesign Services offers both off-the-shell assays using commercial kits and in-house developed assays with customized reagent panels.
Pharmaco-Imaging
DMPK
DMPK
Oncodesign Services studies the pharmacokinetics and metabolism of your new therapeutic entities.
In vivo pharmacology
In vivo pharmacology
From its inception, Oncodesign Services has dedicated efforts to centralize skills, assays and expertise to conduct complete preclinical pharmacological characterization of drugs in the field of oncology, immunology, immune-inflammation or infectious diseases. Our multi-disciplinary team keeps your program moving quickly by providing proof of concept for your lead compounds.
h3>Biophysics
Biophysics plays a crucial role in the early stages of drug discovery by identifying and characterizing small molecules and biologics for specific targets. ZoBio, an associated company of Oncodesign Services, leverages their expertise in this field to provide custom biophysical assays.
Bioanalysis
Oncodesign Services offers formulation, immunogenicity and bioanalytical sample analysis services including platforms for small molecules (NCEs), peptides, large molecules (NBEs), monoclonal antibodies (mAb), Antibody-Drug Conjugates (ADC), Anti-Drug Antibodies (ADA), Neutralizing Antibodies (Nab), oligonucleotides (OGN) and biomarkers (simplex/multiplex).
In vitro biology
Oncodesign Services offers both off-the-shell assays using commercial kits and in-house developed assays with customized reagent panels.
DMPK
Oncodesign Services studies the pharmacokinetics and metabolism of your new therapeutic entities.
In vivo pharmacology
From its inception, Oncodesign Services has dedicated efforts to centralize skills, assays and expertise to conduct complete preclinical pharmacological characterization of drugs in the field of oncology, immunology, immune-inflammation or infectious diseases. Our multi-disciplinary team keeps your program moving quickly by providing proof of concept for your lead compounds.
Who is Oncodesign Services?
Oncodesign Services is a Contract research organization (CRO) specializing in drug discovery and preclinical services. From target identification to IND filing, the company contributes to the development of innovative therapies in oncology, inflammation and infectious diseases, with high medical needs.
Oncodesign Services has 280 employees in France, Canada, the United States and Netherland.
Contact us to exchange on your drug discovery projects !